|
Public |
|
| Computer & Electronics - Semiconductor & MicroChip Manufacturing | |
| over $1B | |
| over 10K | |
| www.ti.com | |
| (214) 479-3773 | |
| (302) 655-5049 | |
TranXenoGen, Inc is a biotechnology company focused on developing methods for manufacturing its own therapeutic proteins, as well as generic biologicals. The Company's technology platform has multiple application potentials, including the generation of transgenic chickens for the manufacture of high volume therapeutic proteins, animal models for the study of disease, and high-throughput production of antibodies from genomic-derived targets for product identification. The first of Company's own therapeutic protein products is Anti-Neoplastic Urinary Protein, developed for the treatment of several types of cancer. The Company also intends to utilize its technology for the production of insulin and human serum albumin. The Company is also exploring licensing both its technology and products f... (Source: SEC reports)
Competitor - 1/8
Which company is more competitive with Texas Instruments?
Jun 22, 2018 07:45:02
DALLAS, June 21, 2018 /PRNewswire/ --Texas Instruments Incorporated (TI) (NASDAQ: TXN) today announced that Martin S. Craighead has been elected to TI\'s board of directors, effective July [...]
Jan 24, 2018 00:15:16
DALLAS, Jan. 18, 2018 /PRNewswire/ --Â Texas Instruments Incorporated (TI) (NASDAQ: TXN) today said that its board of directors has selected Brian Crutcher to become the company\'s next [...]
Oct 6, 2017 20:31:16
DALLAS, Oct. 6, 2017 /PRNewswire/ --Â Texas Instruments Incorporated (TI) (NASDAQ: TXN) will webcast its third-quarter 2017 earnings conference call on Tuesday, October 24, at 4 p.m. Central [...]
Sep 21, 2017 20:30:52
DALLAS, Sept. 21, 2017 /PRNewswire/ --Â Texas Instruments Incorporated (TI) (NASDAQ: TXN) today said it will raise its quarterly cash dividend by 24 percent, from $0.50 per share [...]
Aug 30, 2017 20:30:53
DALLAS, Aug. 30, 2017 /PRNewswire/ --Â Texas Instruments Incorporated (TI) (NASDAQ: TXN) Senior Vice President and Chief Financial Officer Rafael Lizardi will speak at the 2017 Deutsche Bank [...]